ctDNA Testing
Invitation to tender for Circulating tumour DNA (ctDNA) next generation sequencing (NGS) assay.
Buyer
Manchester University NHS Foundation Trust
Value
£30,000,000
Published
6 Mar 2024
Closes
5 Apr 2024
Procurement details
Source
Find a Tender
Region
Greater Manchester South West
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33696500
Laboratory reagents
33696300
Chemical reagents
Lots
Lot 1 ctDNA Testing
£30,000,000
Manchester University NHS Foundation Trust (MFT) has a requirement for ctDNA testing of non-small cell lung cancer, at St Mary’s Hospital, Genomic Medicine. MFT are requiring a ctDNA Next Generation Sequencing (NGS) assay which can detect non-small cell lung cancer. MFT has been indicated by NHS England (NHSE) that it will act as a centre to commission ctDNA...
Delivery: Greater Manchester
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.